Example of Post Reproductive Health format
Recent searches

Example of Post Reproductive Health format Example of Post Reproductive Health format Example of Post Reproductive Health format Example of Post Reproductive Health format Example of Post Reproductive Health format Example of Post Reproductive Health format Example of Post Reproductive Health format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Post Reproductive Health format Example of Post Reproductive Health format Example of Post Reproductive Health format Example of Post Reproductive Health format Example of Post Reproductive Health format Example of Post Reproductive Health format Example of Post Reproductive Health format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Post Reproductive Health — Template for authors

Publisher: SAGE
Categories Rank Trend in last 3 yrs
Obstetrics and Gynecology #97 of 176 -
journal-quality-icon Journal quality:
Medium
calendar-icon Last 4 years overview: 94 Published Papers | 165 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 15/07/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

Taylor and Francis

Quality:  
High
CiteRatio: 4.2
SJR: 0.747
SNIP: 1.109
open access Open Access

SAGE

Quality:  
High
CiteRatio: 4.5
SJR: 0.927
SNIP: 0.926
open access Open Access

Hindawi

Quality:  
High
CiteRatio: 4.1
SJR: 1.18
SNIP: 1.896
open access Open Access

Nature

Quality:  
High
CiteRatio: 3.6
SJR: 0.912
SNIP: 1.249

Journal Performance & Insights

CiteRatio

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

A measure of average citations received per peer-reviewed paper published in the journal.

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

1.8

13% from 2019

CiteRatio for Post Reproductive Health from 2016 - 2020
Year Value
2020 1.8
2019 1.6
2018 1.6
2017 1.7
2016 1.9
graph view Graph view
table view Table view

0.24

39% from 2019

SJR for Post Reproductive Health from 2016 - 2020
Year Value
2020 0.24
2019 0.396
2018 0.257
2017 0.287
2016 0.377
graph view Graph view
table view Table view

0.532

17% from 2019

SNIP for Post Reproductive Health from 2016 - 2020
Year Value
2020 0.532
2019 0.644
2018 0.307
2017 0.504
2016 0.664
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has increased by 13% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

insights Insights

  • SJR of this journal has decreased by 39% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has decreased by 17% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Post Reproductive Health

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

SAGE

Post Reproductive Health

Approved by publishing and review experts on SciSpace, this template is built as per for Post Reproductive Health formatting guidelines as mentioned in SAGE author instructions. The current version was created on 14 Jul 2020 and has been used by 849 authors to write and format their manuscripts to this journal.

Obstetrics and Gynaecology

Medicine

i
Last updated on
14 Jul 2020
i
ISSN
2053-3691
i
Open Access
No
i
Endnote Style
Download Available
i
Bibliography Name
SageV
i
Citation Type
Numbered (Superscripted)
25
i
Bibliography Example
Blonder GE, Tinkham M and Klapwijk TM. Transition from metallic to tunneling regimes in superconducting microconstrictions: Excess current, charge imbalance, and supercurrent conversion. Phys. Rev. B 1982; 25(7): 4515–4532. URL 10.1103/PhysRevB.25.4515.

Top papers written in this journal

Journal Article DOI: 10.1258/136218005775544589
Drug metabolism and ageing.
Hilary Wynne1

Abstract:

Older people are major consumers of drugs and because of this, as well as co-morbidity and age-related changes in pharmacokinetics and pharmacodynamics, are at risk of associated adverse drug reactions. While age does not alter drug absorption in a clinically significant way, and age-related changes in volume of drug distribu... Older people are major consumers of drugs and because of this, as well as co-morbidity and age-related changes in pharmacokinetics and pharmacodynamics, are at risk of associated adverse drug reactions. While age does not alter drug absorption in a clinically significant way, and age-related changes in volume of drug distribution and protein binding are not of concern in chronic therapy, reduction in hepatic drug clearance is clinically important. Liver blood flow falls by about 35% between young adulthood and old age, and liver size by about 24-35% over the same period. First-pass metabolism of oral drugs avidly cleared by the liver and clearance of capacity-limited hepatically metabolized drugs fall in parallel with the fall in liver size, and clearance of drugs with a high hepatic extraction ratio falls in parallel with the fall in hepatic blood flow. In normal ageing, in general, activity of the cytochrome P450 enzymes is preserved, although a decline in frail older people has been noted, as well as in association with liver disease, cancer, trauma, sepsis, critical illness and renal failure. As the contribution of age, co-morbidity and concurrent drug therapy to altered drug clearance is impossible to predict in an individual older patient, it is wise to start any drug at a low dose and increase this slowly, monitoring carefully for beneficial and adverse effects. read more read less
144 Citations
Journal Article DOI: 10.1177/136218079500100106
Osteoporosis and its Management

Abstract:

Fractures caused by osteoporosis affect one in two women and one in five men over the age of 50, resulting in an estimated annual cost to the health services of around £1.8bn (€2.7bn; $3.5bn) in the United Kingdom and €30bn in all of Europe.1 2 Most patients with osteoporosis are managed in primary care, but a minority will b... Fractures caused by osteoporosis affect one in two women and one in five men over the age of 50, resulting in an estimated annual cost to the health services of around £1.8bn (€2.7bn; $3.5bn) in the United Kingdom and €30bn in all of Europe.1 2 Most patients with osteoporosis are managed in primary care, but a minority will benefit from referral to specialised centres. In recent years considerable advances have been made both in the identification of people at high risk of fracture and in therapeutic options to reduce the risk of fracture. This review focuses on these areas and also on the partnership that is required between primary and secondary care to optimise the management of patients with osteoporosis. Osteoporosis results from reduced bone mass and disruption of the micro-architecture of bone (fig 1)⇓, giving decreased bone strength and increased risk of fracture, particularly of the spine, hip, wrist, humerus, and pelvis. The risk of fractures increases steeply with age (fig 2)⇓ and most of those affected are over 75.1 2 Globally, osteoporotic fractures caused an estimated 5.8 million disability adjusted life years in the year 2000w1 and are also associated with increased mortality. Hip fractures (fig 3)⇓ result in loss of independence for at least a third of people with osteoporosis, and vertebral fractures (fig 4)⇓ cause height loss, chronic pain, and difficulty with normal daily activities. Fig 1 Scanning electron micrographs to show the structure of L3 vertebra in a 31 year old woman (top) and in a 70 year old woman (bottom). Note that many of the plate-like structures have become converted to thin rods Fig 2 Epidemiology of osteoporotic fractures in men and women. Reprinted with permission28 Fig 3 Fracture of the femoral neck Fig 4 … read more read less
96 Citations
Journal Article DOI: 10.1258/136218005775544561
Muscle performance after the menopause.
Joonas Sirola1, Toni Rikkonen1

Abstract:

The timing of the menopause transition has remained fairly constant throughout history. It represents a milestone in female health and, after passing through it, women experience increased musculoskeletal and cardiovascular morbidity. Muscle performance is an important determinant of functional capacity and quality of life am... The timing of the menopause transition has remained fairly constant throughout history. It represents a milestone in female health and, after passing through it, women experience increased musculoskeletal and cardiovascular morbidity. Muscle performance is an important determinant of functional capacity and quality of life among the elderly and is also involved in the maintenance of balance. Therefore, good muscle strength can prevent fragility fractures and lessen the burden of osteoporosis. Muscle strength begins to decline during the perimenopausal years and this phenomenon seems to be partly estrogen dependent. Randomized controlled trials have indicated that hormone replacement therapy may prevent a decline in muscle performance, although the exact mechanism of estrogen-dependent sarcopenia remains to be clarified. Exercises have been shown to improve postmenopausal muscle performance and hormone replacement therapy may also potentiate these beneficial effects. Improvement or maintenance of muscle strength alone, however, may not be considered as a primary indication for long-term hormone replacement therapy in view of current knowledge of its risks and benefits. Work history and educational background may be associated with postmenopausal muscle performance, which itself has unique associations with skeletal and cardiovascular diseases. read more read less
74 Citations
Journal Article DOI: 10.1177/136218079800400205
Mechanisms of Transdermal Drug Delivery
Kenneth A. Walters1

Abstract:

The use of the skin as a route of delivery into the systemic circulation has been exploited since the 1950s with the development of ointments containing agents such as nitroglycerin and salicylates. This has been extended since the early 1980s to hormone replacement therapy with the development of skin patches and gels. The s... The use of the skin as a route of delivery into the systemic circulation has been exploited since the 1950s with the development of ointments containing agents such as nitroglycerin and salicylates. This has been extended since the early 1980s to hormone replacement therapy with the development of skin patches and gels. The skin affords a major barrier and the mechanisms of drug transport across it are discussed. Delivery of oestradiol and progestogens are discussed. read more read less
74 Citations
open accessOpen access Journal Article DOI: 10.1177/136218079600200201
The impact of treatment

Abstract:

P remature ovarian failure is defined as gonadal failure before the age of 40 and it is a common condition, affecting I per cent of women I. Tragically, the diagnosis is often delayed and women affected may experience amenorrhoea for several years without receiving medical help. Sub-optimal peak bone mass may result in young ... P remature ovarian failure is defined as gonadal failure before the age of 40 and it is a common condition, affecting I per cent of women I. Tragically, the diagnosis is often delayed and women affected may experience amenorrhoea for several years without receiving medical help. Sub-optimal peak bone mass may result in young women. Chromosomal analysis is needed in those under 30 years of age because of the risk of germ cell tumour. A recent development is the possibility of pregnancy using egg donation, the success rate varying between 25 and 40 per cent depending on the age of the donor. Mary Birdsall ,provides a comprehensive account of chis procedure and the screening of recipients and donors. This important innovation offers hope to many relatively young women who wish to conceive but find they are infertile because of menopause. The ethics of ovum donation will be discussed in a later issue. The best predictor of fracture risk is bone mineral density measurement at sites such as the femoral neck, radius and lumbar spine. This test should be available to general practitioners to read more read less
View PDF
59 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Post Reproductive Health.

It automatically formats your research paper to SAGE formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Post Reproductive Health format uses SageV citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Post Reproductive Health in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Post Reproductive Health guidelines and auto format it.

2. Do you follow the Post Reproductive Health guidelines?

Yes, the template is compliant with the Post Reproductive Health guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Post Reproductive Health?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Post Reproductive Health citation style.

4. Can I use the Post Reproductive Health templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Post Reproductive Health.

5. Can I use a manuscript in Post Reproductive Health that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Post Reproductive Health that you can download at the end.

6. How long does it usually take you to format my papers in Post Reproductive Health?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Post Reproductive Health.

7. Where can I find the template for the Post Reproductive Health?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Post Reproductive Health's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Post Reproductive Health's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Post Reproductive Health an online tool or is there a desktop version?

SciSpace's Post Reproductive Health is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Post Reproductive Health?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Post Reproductive Health?”

11. What is the output that I would get after using Post Reproductive Health?

After writing your paper autoformatting in Post Reproductive Health, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Post Reproductive Health's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Post Reproductive Health?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Post Reproductive Health. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Post Reproductive Health?

The 5 most common citation types in order of usage for Post Reproductive Health are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Post Reproductive Health?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Post Reproductive Health's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Post Reproductive Health in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Post Reproductive Health Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Post Reproductive Health formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template